ADAM17 and Vascular Function in Diabetes

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
The objective of this project is to determine the extent to which administration of the dietary supplement phosphatidylserine (PS), a competitive inhibitor of ADAM17 sheddase activity, effects vascular function and insulin-stimulated leg blood flow in subjects with T2D.
Epistemonikos ID: 4d1ea63ada6944454875948b02709db195bfb0dc
First added on: May 07, 2024